Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 1, 2007, Pages 129-132

  Pai, Manjunath P ^a   Jones, Ariel L ^b   Mullen, Casey K ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Bloodstream; Candida; Micafungin

Indexed keywords

MICAFUNGIN;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CONTROLLED STUDY; CORRELATION ANALYSIS; FUNGUS GROWTH; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BLOOD; CANDIDA; CANDIDIASIS; CULTURE MEDIA; FUNGEMIA; GLUCOSE; HUMANS; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC;

EID: 34247856050     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.10.017     Document Type: Article

References (13)

1. Clemons K.V., Espiritu M., Parmar R., and Stevens D.A. Assessment of the paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob. Agents Chemother. 50 (2006) 1293-1297
2. Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev. Iberoam. Micol. 20 (2003) 121-136
3. Jarvis B., Figgit D.P., and Scott L.J. Micafungin. Drugs 64 (2004) 969-982
4. Magiorakos A.P., and Hadley S. Impact of real-time fungal susceptibility testing on clinical practices. Curr. Opin. Infect. Dis. 17 (2004) 511-515
5. Muller F.M.C., Kurzai O., Hacker J., Frosch M., and Muhlschlegel F. Effect of growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis. J. Antimicrob. Chemother. 48 (2001) 713-715
6. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast; approved standard. M27-A2. 2nd ed. (2002), National Committee for Clinical Laboratory Standards, Wayne, Pa
7. Odds F.C., Motyl M., Andrade R., Bille J., Canton E., Cuenca-Estrella M., Davidson A., Durussel C., Ellis D., Foraker E., Fothergill A.W., Ghannoum M.A., Giacobbe R.A., Gobernado M., Handke R., Laverdiere M., Lee-Yang W., Merz W.G., Ostrosky-Zeichner L., Peman J., Perea S., Perfect J.R., Pfaller M.A., Proia L., Rex J.H., Rinaldi M.G., Rodriguez-Tudela J.L., Schell W.A., Shields C., Sutton D.A., Verweij P.E., and Warnock D.W. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J. Clin. Microbiol. 42 (2004) 3475-3482
8. Park S., Kelly R., Kahn J.N., Robles J., Hsu M.J., Register E., Li W., Vyas V., Fan H., Abruzzo G., Flattery A., Gill C., Chrebet G., Parent S.A., Kurtz M., Teppler H., Douglas C.M., and Perlin D.S. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob. Agents Chemother. 49 (2005) 3264-3273
9. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., and Edwards J.E. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38 (2004) 161-189
10. Pfaller M.A., Wey S., Gerarden T., Houston A., and Wenzel R.P. Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents. Diagn. Microbiol. Infect. Dis. 12 (1989) 1-4
11. Rex J.H., Pfaller M.A., Walsh T.J., Chaturvedi V., Espinel-Ingroff A., Ghannoum M.A., Gosey L.L., Odds F.C., Rinaldi M.G., Sheehan D.J., and Warnock D.W. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14 (2001) 643-658
12. Stevens D.A., Espiritu M., and Parmar R. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48 (2004) 3407-3411
13. To W.K., Fothergill A.W., and Rinaldi M.G. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 33 (1995) 2660-2664